AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

Location

Additional address info

  • S item-insel

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2019
  • Number of employees in Switzerland
    10-19

Keep browsing

You may also be interested in